Val
—
Gro
—
Qua
—
Mom
—
Sta
—
Cap—
P/S0.18
P/E—
Fwd P/E16.24
PEG0.68
52W— – —
RSI—
Target$369.31 (+14.8%)
Beta0.57
Div0.73%
Loading chart…
RSI ()
Loading patterns…
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
Signal
Trend Strength
Price Levels
52-Week Range
52W Low
—
52W High
Position in Range
—
RSI (14)
0 · Oversold
RSI 50
Overbought · 100
Signal
Neutral
EMA Price Levels
Activity & Patterns
Volume Analysis
Momentum Dashboard
Detected Patterns
8Bullish
3Bearish
0Neutral
Key Signals 3
▲ Double Bottom
Major reversal
2026-06-25 · $284.38
Two lows ~$264.78 — bullish reversal confirmed
Learn more →
▲ Double Bottom
Major reversal
2026-08-06 · $322.33
Two lows ~$299.25 — bullish reversal confirmed
Learn more →
▲ Double Bottom
Major reversal
2026-09-02 · $333.3
Two lows ~$301.33 — bullish reversal confirmed
Learn more →
Momentum Signals 8
▲ MACD Bullish Crossover
▲ Bull Flag
▲ MACD Bullish Crossover
▲ Bull Flag
View overlays on the price chart via Overview tab → Pattern Overlays.
EPS — History & Forecast
Estimate
Beat
Miss
Forecast
Loading…
Revenue — History & Forecast
Revenue
Forecast
Loading…
EPS Beat Rate
100%
8/8 quarters
Wall Street Consensus
BUY
BuyHoldSell
Price Target Range
$369.31
+14.8% upside
Low $330
—
High $430
Consensus
Current price
Wall Street Analyst Ratings
Sort by
| Firm | Rating | Change | Action | Date |
|---|
Profitability
Gross Margin
3.96%Last 12 Months
Operating Margin
1.41%Last 12 Months
Return on Equity
96.87%Last 12 Months
Revenue Growth
5.10%Year over Year
Free Cash Flow
2.04BLast 12 Months
Free Cash Flow Yield
—Last 12 Months
Balance Sheet
Debt / Equity
446.52Most Recent Quarter
Current Ratio
0.94Most Recent Quarter
Cash
2.82BMost Recent Quarter
Total Debt
14.46BMost Recent Quarter
Net Debt
—Most Recent Quarter
How COR Makes Its Money
Cash Flow Breakdown
Quarterly Metrics
| Quarter | Revenue | Rev YoY | Gross Profit | Op. Income | Net Income | Net YoY | Gross % | Op % | Net % |
|---|
Full Key Statistics
Valuation
| Market Cap | 61.36B |
| Enterprise Value | 73.20B |
| Trailing P/E | 23.86 |
| Forward P/E | 16.24 |
| PEG Ratio (5yr) | 0.68 |
| Price/Sales (ttm) | 0.18 |
| Price/Book (mrq) | 20.11 |
| EV/Revenue | 0.22 |
| EV/EBITDA | 13.20 |
Share Statistics
| Avg Vol (3m) | 1.48M |
| Shares Outstanding | 190.83M |
| Float | 180.25M |
| % Held by Insiders | 4.30% |
| % Held by Institutions | 99.62% |
| Short Ratio | 3.16 |
| Short % of Float | 2.70% |
Profitability
| Gross Margin | 3.96% |
| Operating Margin (ttm) | 1.41% |
| Profit Margin | 0.79% |
| Return on Assets (ttm) | 3.56% |
| Return on Equity (ttm) | 96.87% |
Income Statement
| Revenue (ttm) | 332.77B |
| Revenue Growth (yoy) | 5.10% |
| Gross Profit (ttm) | 13.18B |
| EBITDA | 5.55B |
| Net Income (ttm) | 2.62B |
| Diluted EPS (ttm) | 13.48 |
| EPS Growth (yoy) | 11.90% |
Balance Sheet
| Total Cash (mrq) | 2.82B |
| Total Debt (mrq) | 14.46B |
| Debt / Equity (mrq) | 446.52 |
| Current Ratio (mrq) | 0.94 |
| Book Value / Share | 15.99 |
| Operating CF (ttm) | 4.82B |
| Free Cash Flow (ttm) | 2.04B |
Trading & Dividends
| Beta (5Y) | 0.57 |
| 50-Day MA | 314.47 |
| 200-Day MA | 321.35 |
| Fwd Dividend Yield | 0.75% |
| Payout Ratio | 17.45% |
Income
Dividend Yield
0.73%Last 12 Months
Annual Rate
2.40Forward
Payout Ratio
17.45%Last 12 Months
Dividend History
Payout Ratio (Last 12 Months): 17.45%
Monthly Dividends
Ownership Breakdown
Institutional 99.62%
Insider 4.30%
Short Interest
2.70% of float
Low
Institutional 13F Holdings
Famous investors who disclosed a position in COR in their latest SEC 13F filing.
Loading…
Insider Transactions
| Date | Insider | Role | Transaction | Shares | Price | Value |
|---|